methionine sulfoximine has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, ML; Lim, JC; Shivashankar, G | 1 |
| Packer, L | 1 |
1 review(s) available for methionine sulfoximine and Diabetic Retinopathy
| Article | Year |
|---|---|
Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts.
Topics: Animals; Antimetabolites; Antioxidants; Buthionine Sulfoximine; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Female; Humans; Lens, Crystalline; Methionine Sulfoximine; Rats; Rats, Wistar; Thioctic Acid | 1994 |
1 other study(ies) available for methionine sulfoximine and Diabetic Retinopathy
| Article | Year |
|---|---|
Glyceraldehyde-3-phosphate dehydrogenase and glutamine synthetase inhibition in the presence of pro-inflammatory cytokines contribute to the metabolic imbalance of diabetic retinopathy.
Topics: Adenosine Triphosphate; Animals; Blotting, Western; Diabetic Retinopathy; Enzyme Inhibitors; Female; Glucose; Glutamate-Ammonia Ligase; Glyceraldehyde-3-Phosphate Dehydrogenases; Hyperglycemia; Interleukin-1beta; Iodoacetic Acid; L-Lactate Dehydrogenase; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Retina; Tumor Necrosis Factor-alpha | 2021 |